Essais p53

25 produits

p53 est un gène codé par le symbole TP53. Communément appelé aussi: Cellular tumor antigen Antigen NY-CO-13; Phosphoprotein Tumor suppressor TP53. p53 a une masse de 43.65kDa, une longueur d'acide aminé de 393, et est impliqué dans les maladies: Esophageal cancer; Li-Fraumeni syndrome; Squamous cell carcinoma of the head and neck; Lung cancer; Papilloma of choroid plexus; Adrenocortical carcinoma; Basal cell carcinoma 7; Bone marrow failure syndrome 5.

Nous proposons 25 p53 kits ELISA pour la détection qualitative ou quantitative de p53 à partir d'échantillons Humain, Souris et Rat.

Informations sur les Gènes et les Protéines

Résumé UniProt
Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 (PubMed:12524540). However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP (PubMed:12524540). In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-ARNTL/BMAL1-mediated transcriptional activation of PER2 (PubMed:24051492).
Résumé Entrez
This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277).
Spécificité tissulaire
Ubiquitous. Isoforms are expressed in a wide range of normal tissues but in a tissue-dependent manner. Isoform 2 is expressed in most normal tissues but is not detected in brain, lung, prostate, muscle, fetal brain, spinal cord and fetal liver. Isoform 3 is expressed in most normal tissues but is not detected in lung, spleen, testis, fetal brain, spinal cord and fetal liver. Isoform 7 is expressed in most normal tissues but is not detected in prostate, uterus, skeletal muscle and breast. Isoform 8 is detected only in colon, bone marrow, testis, fetal brain and intestine. Isoform 9 is expressed in most normal tissues but is not detected in brain, heart, lung, fetal liver, salivary gland, breast or intestine.
Implication dans la maladie
Esophageal cancer: A malignancy of the esophagus. The most common types are esophageal squamous cell carcinoma and adenocarcinoma. Cancer of the esophagus remains a devastating disease because it is usually not detected until it has progressed to an advanced incurable stage.

Li-Fraumeni syndrome: An autosomal dominant familial cancer syndrome that in its classic form is defined by the existence of a proband affected by a sarcoma before 45 years with a first degree relative affected by any tumor before 45 years and another first degree relative with any tumor before 45 years or a sarcoma at any age. Other clinical definitions for LFS have been proposed and called Li-Fraumeni like syndrome (LFL). In these families affected relatives develop a diverse set of malignancies at unusually early ages. Four types of cancers account for 80% of tumors occurring in TP53 germline mutation carriers: breast cancers, soft tissue and bone sarcomas, brain tumors (astrocytomas) and adrenocortical carcinomas. Less frequent tumors include choroid plexus carcinoma or papilloma before the age of 15, rhabdomyosarcoma before the age of 5, leukemia, Wilms tumor, malignant phyllodes tumor, colorectal and gastric cancers.

Squamous cell carcinoma of the head and neck: A non-melanoma skin cancer affecting the head and neck. The hallmark of cutaneous SCC is malignant transformation of normal epidermal keratinocytes.

Lung cancer: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis.

Papilloma of choroid plexus: A benign tumor of neuroectodermal origin that generally occurs in childhood, but has also been reported in adults. Although generally found within the ventricular system, choroid plexus papillomas can arise ectopically in the brain parenchyma or disseminate throughout the neuraxis. Patients present with signs and symptoms of increased intracranial pressure including headache, hydrocephalus, papilledema, nausea, vomiting, cranial nerve deficits, gait impairment, and seizures.

Adrenocortical carcinoma: A malignant neoplasm of the adrenal cortex and a rare childhood tumor. It occurs with increased frequency in patients with Beckwith-Wiedemann syndrome and Li-Fraumeni syndrome.

Basal cell carcinoma 7: A common malignant skin neoplasm that typically appears on hair-bearing skin, most commonly on sun-exposed areas. It is slow growing and rarely metastasizes, but has potentialities for local invasion and destruction. It usually develops as a flat, firm, pale area that is small, raised, pink or red, translucent, shiny, and waxy, and the area may bleed following minor injury. Tumor size can vary from a few millimeters to several centimeters in diameter.

Bone marrow failure syndrome 5: A form of bone marrow failure syndrome, a heterogeneous group of life-threatening disorders characterized by hematopoietic defects in association with a range of variable extra hematopoietic features. BMFS5 is an autosomal dominant form characterized by infantile onset of severe red cell anemia requiring transfusion. Additional features include hypogammaglobulinemia, poor growth with microcephaly, developmental delay, and seizures.
Similitudes de séquence
Belongs to the p53 family.
Modification post-traductionnelle
Acetylated. Acetylation of Lys-382 by CREBBP enhances transcriptional activity. Deacetylation of Lys-382 by SIRT1 impairs its ability to induce proapoptotic program and modulate cell senescence. Deacetylation by SIRT2 impairs its ability to induce transcription activation in a AKT-dependent manner.
Localisation cellulaire
Cytoplasm. Nucleus. Nucleus > PML body. Endoplasmic reticulum. Mitochondrion matrix. Cytoplasm > Cytoskeleton > Microtubule organizing center > Centrosome.

Interaction with BANP promotes nuclear localization (PubMed:15701641). Recruited into PML bodies together with CHEK2 (PubMed:12810724). Translocates to mitochondria upon oxidative stress (PubMed:22726440). Translocates to mitochondria in response to mitomycin C treatment (PubMed:27323408).
Standard Curve - Rat p53 ELISA Kit (A80193) - Antibodies.com
Standard Curve - Mouse p53 ELISA Kit (A77444) - Antibodies.com
Standard Curve - Human p53 ELISA Kit (A77443) - Antibodies.com
Western Blot - p53 (phospho Ser20) Cell Based ELISA Kit (FLUO-CBP1187) - Antibodies.com
(4)
Western Blot - p53 Cell Based ELISA Kit (CB5518) - Antibodies.com
(4)
Western Blot - p53 (phospho Thr18) Cell Based ELISA Kit (CBP1649) - Antibodies.com
(4)
Western Blot - p53 (phospho Ser20) Cell Based ELISA Kit (CBP1187) - Antibodies.com
(4)
Western Blot - p53 (phospho Ser15) Cell Based ELISA Kit (CBP1642) - Antibodies.com
(4)
Western Blot - p53 (phospho Ser315) Cell Based ELISA Kit (CBP1643) - Antibodies.com
(4)
Western Blot - p53 (phospho Ser46) Cell Based ELISA Kit (CBP1646) - Antibodies.com
(4)
Validation Data - p53 (phospho Ser20) ELISA Kit (TFE-7186) - Antibodies.com
(2)
Western Blot - p53 (phospho Ser37) Cell Based ELISA Kit (CBP1645) - Antibodies.com
(4)
Validation Data - p53 (Acetyl-Lys317) ELISA Kit (TFE-7189) - Antibodies.com
(2)
Western Blot - p53 (phospho Ser33) Cell Based ELISA Kit (CBP1644) - Antibodies.com
(4)
Western Blot - p53 (phospho Ser6) Cell Based ELISA Kit (CBP1647) - Antibodies.com
(4)
Validation Data - p53 (phospho Thr18) ELISA Kit (TFE-7188) - Antibodies.com
(2)
Western Blot - p53 (phospho Ser366) Cell Based ELISA Kit (CBP1727) - Antibodies.com
(4)
Western Blot - p53 (phospho Ser9) Cell Based ELISA Kit (CBP1648) - Antibodies.com
(4)
Validation Data - p53 ELISA Kit (TFE-7124) - Antibodies.com
(2)
Validation Data - p53 (phospho Ser376) ELISA Kit (TFE-7123) - Antibodies.com
(2)
Validation Data - p53 (phospho Ser315) ELISA Kit (TFE-7122) - Antibodies.com
(2)
Validation Data - p53 (phospho Ser392) ELISA Kit (TFE-7121) - Antibodies.com
(2)
Antibodies.com Image Placeholder - Discover more for less
Validation Data - p53 (phospho Ser33) ELISA Kit (TFE-7187) - Antibodies.com
(2)
Standard Curve - Human p53 ELISA Kit (BEK1183) - Antibodies.com

Affichage de 1-25 sur 25 produits

Filtres Menu Principal Nous Contacter 0Caisse
Haut